Horumarinta warshadaha dawooyinka caalamiga ah ee 2023 ayaa wali ku jira xilli naxdin leh, halka shirkadaha dawooyinka gudaha iyo kuwa shisheeye ay sidoo kale fiiro gaar ah siin doonaan maalgashiga R&D.Tobanka sano ee soo socda, warshadaha dawooyinka ayaa laga yaabaa inay weli la kulmaan isbeddello waaweyn, isbeddelka ugu weyn waa deegaanka siyaasadda caalamiga ah.Deegaanka isbeddelka weyni ka jiro, shirkadaha dawooyinka ayaa sidoo kale leh habab kala duwan oo ay wax uga qabtaan, sida soo-celinta alaabta, laanta suuq-geynta, hal-abuurka moodeelka iyo wixii la mid ah.
Shirkadaha dawooyinka ayaa sidoo kale wajahaya caqabado waaweyn oo xagga sare ah.Hadda, shirkadaha dawooyinka ayaa fiiro gaar ah u leh maalgashiga R&D waxayna kordhiyaan miisaaniyada. Cilmi baaristu waxay muujineysaa in qaar ka mid ah shirkadaha caanka ah ay maal galiyeen ilaa 3.6 bilyan cilmi baarista iyo horumarinta, iyo tallaalka CanSino ee COVID-19 ayaa ku qaatay in ka badan 1.014 bilyan gudaha Maalgelinta R&D.Iyo BeiGene's TIGIT inhibitor-ku wuxuu maalgashaday $2.9 bilyan, Rongchang Bio's Vidicumumab wuxuu maalgeliyay $2.6 bilyan.Isla mar ahaantaana, sannadihii la soo dhaafay, isbeddelka cudurrada bini'aadamka, daawooyinka bayoolojiga ayaa sidoo kale ku jira baahida sii kordheysa, shirkado badan ayaa dejinaya habka R & D bayooloji.g.
Hunan Honya Biotec Co., Ltd. waxa ay ka go'an tahay in ay soo saarto qalabka DNA-ga ee horumarsan iyo xalalka isku dhafan ee isku dhafan in ka badan 10 sano.Cilmi-baadhis madax-bannaan iyo naqshad horumarineed, koox laf dhabar u ah in ka badan 20 macalimiin bayooloji ah iyo injineero ka soo qalin jabiyay Jaamacadda Tsinghua.Waxaan ku siin karnaa agab cayriin oo tayo sare leh oo loogu talagalay maadooyinka cilmi-baarista nolosha sida cilmi-baarista hidda-wadaha, ogaanshaha molecular, horumarinta daroogada nucleic acid, iwm. hufnaan.Si wada jir ah uga wada shaqee si aad u caawiso horumarinta iyo horumarka warshadaha biomedical ee loo marayo qarni cusub.
.
Waqtiga boostada: Abriil-18-2023